Posted by
on Jun 30th, 2011 and filed under Avastin, the FDA and a question of effectiveness (not hope) – Los Angeles Times
 CBC.ca |
Avastin, the FDA and a question of effectiveness (not hope)
Los Angeles Times Avastin is known as a cancer fighter, but its biggest battles lately have been with the Food and Drug Administration. In the latest round, an FDA panel unanimously ruled that the drug should no … Roche Loss on Avastin Appeal Is Third in a Row at FDA Panel FDA Stance on Avastin Irks Lawmakers Medicare to Keep Paying for Controversial Cancer Drug Avastin |
